Akila Mayeda

8PUBLICATIONS
11CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Software quality, processes and metricsPredictive and prognostic markersSequence analysis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 17, 2025
RBM17 Promotes the Chemoresistance of Oral Squamous Cancer Cells Through Checkpoint Kinase 1.

Miyuka Nakahara, Ryosuke Arai, Isao Tokuoka

|Jan 15, 2024
Structural differences between the closely related RNA helicases, UAP56 and URH49, fashion distinct functional apo-complexes.

Ken-Ichi Fujita, Misa Ito, Midori Irie

|Apr 14, 2022
SPF45/RBM17-dependent splicing and multidrug resistance to cancer chemotherapy.

Kazuhiro Fukumura, Julian P Venables, Akila Mayeda

|Mar 10, 2022
Epstein-Barr Virus Enhances Cancer-Specific Aberrant Splicing of TSG101 Pre-mRNA.

Huey-Huey Chua, Toshiki Kameyama, Akila Mayeda

|Aug 14, 2021
SPF45/RBM17-dependent, but not U2AF-dependent, splicing in a distinct subset of human short introns.

Kazuhiro Fukumura, Rei Yoshimoto, Luca Sperotto

|Jul 02, 2021
The Exon Junction Complex Core Represses Cancer-Specific Mature mRNA Re-splicing: A Potential Key Role in Terminating Splicing.

Yuta Otani, Ken-Ichi Fujita, Toshiki Kameyama

Pageof 2

Frequent Collaborators

4 joint publications

Kazuhiro Fukumura

2 joint publications

Te-Huei Yeh

2 joint publications

Toshiki Kameyama

1 joint publications

Rei Yoshimoto